2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Genomics, technology, bioinformatics 0<br />
method to detect sequence variations . PCR is performed in the presence<br />
<strong>of</strong> a saturating dsDNA binding dye . Single-base variations in the<br />
amplicon result in altered melting behaviour after heteroduplex formation,<br />
visualised by HRM plots . The LightCycler® 480 performs both<br />
PCR and HRM in one run .<br />
BRCA1 and BRCA2 were chosen as target genes, because their size<br />
and mutation spectrum represent a challenge in molecular diagnostics<br />
. Current methods, like dHPLC and DGGE, despite their good performance,<br />
are limited by throughput or labour-intensity .<br />
HRM is potentially useful for solving these problems . However, it needs<br />
to be shown that the sensitivity and the user-friendliness are at least as<br />
good as the current state <strong>of</strong> the art . We set up an extensive validation<br />
in 3 laboratories .<br />
The first objective was to design a complete primer set for BRCA1<br />
and BRCA2 . Indeed, the performance <strong>of</strong> HRM is largely depending on<br />
PCR quality. Critical criteria were specific banding patterns after gel<br />
electrophoresis, sigmoid curves on real-time PCR plots and less than<br />
3 melting domains per amplicon .<br />
About 300 known variations are being tested in a blinded way . This will<br />
allow us to determine whether HRM reaches a sensitivity close to 99%,<br />
which would make it a suitable new method for diagnostic use .<br />
P08.40<br />
interlaboratory validation study <strong>of</strong> High Resolution melting<br />
curve Analysis for mutation scanning <strong>of</strong> BRcA1 using the<br />
Lightscanner (it)<br />
N. van der Stoep 1 , C. D. M. van Paridon 1 , A. Stambergova 2 , P. Norambuena 2 ,<br />
M. Macek 2 , T. Janssens 3 , G. Matthijs 3 , E. Bakker 1 ;<br />
1 Center for <strong>Human</strong> and Clinical <strong>Genetics</strong>, Leiden, The Netherlands, 2 Institute<br />
<strong>of</strong> Biology and Medical <strong>Genetics</strong>, Prague, Czech Republic, 3 Center for <strong>Human</strong><br />
<strong>Genetics</strong>, Leuven, Belgium.<br />
The current set up for mutation scanning <strong>of</strong> BRCA1 occurs through<br />
sequence analysis, DGGE, PTT and DHPLC . All these techniques<br />
are time consuming and expensive . Therefore we have evaluated the<br />
High-Resolution Melting Curve Analysis (HR-MCA) as a high-throughput<br />
mutation-scanning tool for the BRCA1 gene using LightScanner<br />
from Idaho Technology (IT) and the LightScanner-MasterMix . This<br />
study was implemented in the EuroGentest evaluation program for<br />
new techniques in genome diagnostics . Investigations were carried out<br />
using a panel <strong>of</strong> >189 variants and 327 wt controls . We optimized and<br />
evaluated 58 primer-sets that cover BRCA1 . All heterozygous variants<br />
could be detected using the Call-IT-1 .5 s<strong>of</strong>tware resulting in a 100%<br />
mutation-detection sensitivity . These variants also include small DNA<br />
deletions and insertions . Out <strong>of</strong> 327 wts we observed 3,7% false positive<br />
curves (FP) resulting in a specificity <strong>of</strong> 96%. Re-evaluation <strong>of</strong> ten<br />
BRCA1-amplicons in the two other diagnostic laboratories gave rise<br />
to identical results . Moreover using unlabeled probes we were able to<br />
identify many frequent occurring polymorphisms, omitting unnecessary<br />
sequence analysis . Finally we selected a set <strong>of</strong> 41 best-performing<br />
primers that encompass the entire BRCA1 gene using stringent criteria<br />
and performed 2 blind tests on 27 patient DNA samples that were sequenced<br />
in parallel. Optimal HR-MC analyses setting were fixed based<br />
on the results obtained with our large set <strong>of</strong> known control samples . In<br />
both series we detected all heterozygous variants and observed a FPscore<br />
<strong>of</strong> 1,8% . In conclusion, HR-MCA with the LightScanner appears<br />
to be a rapid and sensitive method for mutation scanning .<br />
P08.41<br />
Isolation and transcriptional pr<strong>of</strong>iling <strong>of</strong> embryonic human<br />
neural crest cells<br />
S. Thomas 1 , M. Thomas 1 , P. Wincker 2 , P. Xu 3 , M. C. Speer 3 , A. Munnich 1 , S.<br />
Lyonnet 1 , M. Vekemans 1 , H. C. Etchevers 1 ;<br />
1 INSERM U781, PARIS, France, 2 GENOSCOPE (CEA) and UMR 8030 CNRS-<br />
GENOSCOPE-Université d’Evry, Evry, France, 3 Center for <strong>Human</strong> <strong>Genetics</strong>,<br />
Department <strong>of</strong> Medicine, Duke University Medical Center, Durham, NC, United<br />
States.<br />
Developmental and stem cell biology ask the common question <strong>of</strong> how<br />
functionally distinct cell types arise from one self-renewing founder<br />
population . <strong>Human</strong> neural crest cells (hNCC) form in the embryo at the<br />
end <strong>of</strong> the first month <strong>of</strong> pregnancy, although the precise dates have<br />
remained elusive . Most NCC differentiate completely into melanocytes,<br />
all components <strong>of</strong> the peripheral nervous system, certain endocrine<br />
cells and connective and structural tissues in the head, although par-<br />
tially competent NCC progenitors continue to reside in many tissues<br />
in animal models . Due to their inaccessibility and despite their developmental<br />
importance, the original properties and restriction <strong>of</strong> hNCC<br />
potential over time have never been examined . Here, we demonstrate<br />
when and how to isolate self-renewing hNCC and report the resultant<br />
study <strong>of</strong> their transcriptome by serial analysis <strong>of</strong> gene expression<br />
(SAGE) . In addition to highlighting candidate disease genes, we have<br />
identified novel markers that distinguish hNCC from other human cell<br />
types and distinguished between evolutionarily conserved and species-specific<br />
NCC properties. Genome-wide analysis, using multiple<br />
statistical criteria, demonstrates that the global molecular signature <strong>of</strong><br />
early migratory hNCC is remarkably similar to that <strong>of</strong> pluripotent human<br />
embryonic stem cells . We show that most cell types <strong>of</strong> the human<br />
pharyngula express a number <strong>of</strong> genes in situ that, individually, do not<br />
autonomously confer pluripotency but taken within the context <strong>of</strong> the<br />
transcriptome, may be permissive for the unique plasticity <strong>of</strong> hNCC<br />
over time. Our findings pave the way for further studies <strong>of</strong> hNCC therapeutic<br />
potential in neurocristopathies such as peripheral demyelinating<br />
disorders .<br />
P08.42<br />
<strong>Human</strong> Leukocyte Antigen (HLA) typing and sequence-Based<br />
typing (sBt) for Blood stem cell transplants<br />
N. Cereb1 , L. L. Xu2 , E. Vennemeyer2 , S. Jankowski2 , S. Y. Yang1 ;<br />
1 2 Histo<strong>Genetics</strong>, Ossining, NJ, United States, Applied Biosystems, Foster City,<br />
CA, United States.<br />
<strong>Human</strong> leukocyte antigens (HLA) are protein markers that are found<br />
on most <strong>of</strong> the body’s cells . The immune system uses HLA to recognize<br />
which cells belong in your body and which do not . These protein<br />
markers help identify a person’s tissue type . The HLA proteins are important<br />
in matching patients and donors for a bone marrow, peripheral<br />
blood cell (PBSC)or cord blood transplant . When a transplant center<br />
looks at the match level, it is looking at how alike the HLA tissue types<br />
<strong>of</strong> the patient and the donor are to each other .<br />
We will demonstrate that directed sequencing <strong>of</strong> over 40 PCR-amplicons<br />
(including forward/reverse) in the HLA-Class I region provides a<br />
complete test result for each patient . Even one amino acid variation in<br />
each HLA gene between the donor and recipient increases transplant<br />
mortality risk by 10% . Using an exact sequencing match will greatly<br />
improve the patient’s chances <strong>of</strong> transplant success .<br />
Direct sequencing for HLA typing gives the accurate and ultimate answer,<br />
without a timely screening step prior to sequencing . Using state<strong>of</strong>-art<br />
automated capillary electrophoresis instrumentation and bioinformatics<br />
tools to deliver these results saves lives by reducing time<br />
before a donor is located, increasing successful transplant outcome<br />
and lowering subsequent healthcare cost .<br />
P08.43<br />
conserved and non-conserved transcription regulatory elements<br />
associated with siNEs in mammalian promoters<br />
N. V. Tomilin;<br />
Russian Academy <strong>of</strong> Sciences, St.Petersburg, Russian Federation.<br />
About half <strong>of</strong> promoters <strong>of</strong> protein-coding genes in the mouse and<br />
human genomes contain sequences <strong>of</strong> interspersed repeats which<br />
can effect gene expression . Recent estimations suggest that some <strong>of</strong><br />
these sequences are evolutionary conserved and may represent >5%<br />
<strong>of</strong> all constrained nonexonic elements which are under strong purifying<br />
selection in mammalian genomes . However, major fraction <strong>of</strong> important<br />
regulatory elements is not constrained in evolution . These elements<br />
can be recruited from a large pool <strong>of</strong> lineage-specific dispersed<br />
repeats . For example, human Alu and mouse B1 repeats contain short<br />
conserved segments with potential binding site for transcription factor<br />
PitX2 (binding motif YTGGGATTANW) which is important for establishement<br />
<strong>of</strong> left-right asymmetry in development <strong>of</strong> multiple organs .<br />
Alu-associated binding sites for PitX2 regulate expression <strong>of</strong> human<br />
PLOD1 and ANF genes but most <strong>of</strong> downstream target genes for PitX2<br />
is not established . Our results indicate that >1000 <strong>of</strong> mouse or human<br />
genes contain Alu/B1 associated PitX2 binding sites and these genes<br />
are expressed in almost all tissues . >100 <strong>of</strong> these promoters also have<br />
potential binding site for transcription factor Nkx2 .5 (motif TYAAGTG)<br />
which frequently cooperates with PitX2 in gene regulation . Among<br />
PitX2 and Nkx2 .5 targets in the mouse genome we found promoters<br />
<strong>of</strong> SMARCD3, PRKCZ and NIPA1 genes expressed at high level in